Health Care Costs

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

Pomalidomide Plus Dexamethasone Effective in R/R Multiple Myeloma

By

Researchers report on their findings of a retrospective study that compared pomalidomide plus dexamethasone vs dexamethasone alone in patients with relapsed/refractory multiple myeloma.

Better Postoperative Outcomes With RAMIE for Esophageal Cancer

Better Postoperative Outcomes With RAMIE for Esophageal Cancer

By

Research presented at the 2018 Gastrointestinal Cancers Symposium described benefits seen with RAMIE vs chemotherapy or chemoradiotherapy plus OTE for esophageal cancer.

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Ovarian Cancer Screening Potentially Cost-Effective in the United States

Multimodal screening is more expensive, but reduces ovarian cancer mortality, researchers found.

Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden

Relapsed Ph-Negative Acute Lymphoblastic Leukemia Incurs a High Economic Burden

By

Recent study findings investigated the economic burden of patients with relapsed Ph-negative ALL, and the adverse events of special interest that are most likely to have the greatest impact. These findings were presented at ASH 2017.

Physical Examination Sufficient Work-up for Complaints of Breast Pain

Physical Examination Sufficient Work-up for Complaints of Breast Pain

By

A single-center analysis demonstrates likelihood that mastalgia indicates presence of breast cancer and extensiveness of common work-up for the complaint. These findings were presented at SABCS 2017.

Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors

Symptoms, Economic Burden Reduce QoL in Gastrointestinal Cancer Survivors

By

A cross-sectional survey revealed the impact of symptoms and economic burden on quality of life for survivors of gastrointestinal cancer.

Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits

Surveillance Plus FIT for CRC Screening: Additional Costs Not Justified by Benefits

By

Investigators sought to determine clinical and cost effectiveness of additional colonoscopy screening in patients undergoing FIT screening for colorectal cancer.

Cost of Care Significantly Increased With Carcinoid Syndrome in NETs

Cost of Care Significantly Increased With Carcinoid Syndrome in NETs

By

Development of carcinoid syndrome has a profound effect on cost of care for patients with neuroendocrine tumors (NETs).

Median Cost of Cancer Drug Development is Approximately $648 Million

Median Cost of Cancer Drug Development is Approximately $648 Million

Total revenue from sales of 10 drugs was 67.0 billion, with total RD spending of 7.2 billion, researchers found.

Insured Patients with Cancer May Experience Financial Distress

Insured Patients with Cancer May Experience Financial Distress

By

Cancer treatment is far costlier than expected, even for patients with cancer who have health insurance coverage, with being underinsured causing in the most distress for patients.

Poll: Many Seniors Struggling With Drug Costs Don't Seek Help

Poll: Many Seniors Struggling With Drug Costs Don't Seek Help

Roughly half of older Americans experiencing difficulty paying for needed drugs did not talk to their physicians about the issue, poll shows.

Clinical Trials May Benefit Oncology Patients

Clinical Trials May Benefit Oncology Patients

By

Research on the effects of research demonstrated that oncology-related clinical trials provide measurable benefits in terms

New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer

New Study Questions Standard Dosage for Treating Metastatic Non-Small Cell Lung Cancer

By

Doses May Be Adjusted for Treating NSCLC Patients

Can Biosimilars Help Achieve the Goals of US Health Care Reform?

Can Biosimilars Help Achieve the Goals of US Health Care Reform?

[Cancer Management and Research] This research examines the pros and cons of the Affordable Care Act enactment and the possible beneficial role biosimilars may play in this environment.

Young Cancer Survivors More Often Have Cost-Related Nonadherence

Young Cancer Survivors More Often Have Cost-Related Nonadherence

Risk of nonadherence was lower for survivors reporting a usual source of care than those without

United States Leads in Income-Based Health Care Inequalities

United States Leads in Income-Based Health Care Inequalities

More public tolerance for health care inequalities has been observed in the United States than other countries.

Obesity Increases Costs Across Health Care Settings

Obesity Increases Costs Across Health Care Settings

Percentage increases in costs associated with obesity were highest for medications, higher for women

Tai Chi Effective, Affordable Alternative to CBT-I for Insomnia in Breast Cancer Survivors

Tai Chi Effective, Affordable Alternative to CBT-I for Insomnia in Breast Cancer Survivors

By

Tai chi is as effective as cognitive behavioral therapy for insomnia (CBT-I) for the treatment of insomnia in breast cancer survivors.

Costs High for Myeloma Patients Not Getting Low-Income Subsidy

Costs High for Myeloma Patients Not Getting Low-Income Subsidy

For those aged 75 to 84 years, LIS receipt linked to increased odds of receiving immunomodulatory drugs

Proposed Health Care Act Could Result in 23 Million Losing Insurance

Proposed Health Care Act Could Result in 23 Million Losing Insurance

Although premiums may lower over the long-term, many would face much higher out-of-pocket costs under the new plan.

Plan Suggests Ways for Reducing Health Care Costs

Plan Suggests Ways for Reducing Health Care Costs

Nine-point plan includes streamlining billing, reducing high facility fees, and reducing drug costs.

Many Americans Concerned About ACA Repeal

Many Americans Concerned About ACA Repeal

Only twenty percent of Americans support repeal of the Affordable Care Act (ACA), but overall opinions differ by political affiliation.

Putting a Name on the Impact of Cancer Treatment Costs

Putting a Name on the Impact of Cancer Treatment Costs

By

I hear the term "financial toxicity" used more and more when people are discussing the cost of cancer treatments. What exactly is financial toxicity?

Barriers in Routine Care Coverage for Cancer Clinical Trial Participants Still Exist

Barriers in Routine Care Coverage for Cancer Clinical Trial Participants Still Exist

By

Despite the ACA mandate on coverage for clinical trial participants, many facilities involved in cancer research still coping with insurance denials for participants.

Postoperative Outcomes Similar With Mobile App Follow-up for Ambulatory Breast Reconstruction

Postoperative Outcomes Similar With Mobile App Follow-up for Ambulatory Breast Reconstruction

By

Follow-up via mobile app similar to in-person postoperative visits for low-risk ambulatory patients after breast reconstruction.

Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations

Free Lung Cancer Screening Findings Support Continual Screenings in High-Risk Populations

By

A free lung cancer screening program in Augusta, Georgia, found more than double the lung cancer rate of previous screenings.

Discharge Events Improved With Standardized Inpatient Palliative Care Consultation

Discharge Events Improved With Standardized Inpatient Palliative Care Consultation

By

Standardized palliative care consultations for patients with advanced cancer improved postdischarge activities and use of services.

Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer

Evidenced-Based Radiation Treatment Tied to Cost Savings in Early Stage Breast Cancer

By

Health care costs lower for early-stage breast cancer when adjuvant radiation therapy follows evidence-based guidelines.

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

Moderate Hypofractionation Effective, Cost-Efficient, and Tolerable in Prostate Cancer

By

Shorter course of higher dose radiation therapy provide effective treatment, costs less, and is easier on patients than current standard radiation therapy course.

Majority of Health Care Providers Can Offer Cost Estimates

Majority of Health Care Providers Can Offer Cost Estimates

Although 75 percent of provider organizations can offer estimate, less than 25 percent of patients request one.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs